Divita Charles III

CHIEF EXECUTIVE OFFICER, DirectorTeladoc Health, Inc. (TDOC) · full profile →Form 4 · filed Mar 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$257K
Net Open-Market Flow
-$257K
Transactions
7
3 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)50K$5.12$257K328K
Feb 27, 2026Option exercise(M)8K378K
Feb 27, 2022Option exercise(M)169K370K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2026Grant(A)692K$0692K
Feb 27, 2026Grant(A)24K$024K
Feb 27, 2026Option exercise(M)8K$016K
Feb 27, 2026Option exercise(M)169K$0338K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001347535-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly: